ClinConnect ClinConnect Logo
Search / Trial NCT06871059

Effectiveness, Implementation and Spillover Effects of a Culturally Adapted DPP in Spanish Primary Care Centers

Launched by UNIVERSITY OF THE BALEARIC ISLANDS · Mar 6, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Diabetes Prevention Program Prediabetes Type 2 Diabetes Lifestyle Disease Prevention Diet Physical Activity

ClinConnect Summary

Alongside type 2 diabetes (T2D), prediabetes prevalence is also rising, placing a significant burden on public health systems, individuals, and their families.

Promoting a healthy lifestyle that includes regular physical activity, a healthy diet, smoking cessation, and achieving and maintaining a healthy body weight can effectively prevent or delay T2D onset. Major diabetes prevention trials, such as the Diabetes Prevention Program (DPP) in the United States, have demonstrated that intensive lifestyle interventions can significantly reduce T2D risk in individuals with prediabetes.However, ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥18 years; body mass index (BMI) of ≥25 kg/m2 (≥23 kg/m2, if Asian); fasting plasma glucose (FPG) between 1010 and 125 mg/dL, or plasma glucose of 140 to 199 mg/dl measured 2 hours after a 75 g glucose load, or HbA1c between 5.7% and 6.4%, or with a documented history of gestational diabetes mellitus during a previous pregnancy.
  • Exclusion Criteria:
  • Previous diagnosis of type 1 or type 2 diabetes; current use of antidiabetic medications; pregnancy at time of enrollment; terminal illness; institutionalization; dementia or significant cognitive impairment; major surgery or hospitalization in the previous 3 months; presence of any medical or psychological condition limiting participation; and concomitant active participation in another clinical trial.

Trial Officials

Miquel Bennasar-Veny, PhD

Principal Investigator

University of the Baleric Islands

About University Of The Balearic Islands

The University of the Balearic Islands (UIB) is a leading academic institution dedicated to advancing research and education in the health sciences. With a strong emphasis on innovation and interdisciplinary collaboration, UIB conducts clinical trials aimed at improving patient outcomes and enhancing healthcare practices. The university fosters an environment that promotes rigorous scientific inquiry and ethical standards, ensuring that studies are designed and executed with the highest level of integrity. Through its commitment to excellence in research, UIB contributes to the development of evidence-based medical knowledge and the training of future healthcare professionals.

Locations

Palma De Mallorca, Balearic Islands, Spain

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported